| 000 | 01876 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515143757.0 | ||
| 264 | 0 | _c20090817 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1878-1705 | ||
| 024 | 7 |
_a10.1016/j.intimp.2008.09.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSarmiento, Elizabeth | |
| 245 | 0 | 0 |
_aImmune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cJun 2009 |
||
| 300 |
_a649-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHeart Transplantation _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins _xblood |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMonitoring, Immunologic |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRegression Analysis |
| 700 | 1 | _aLanio, Nallibe | |
| 700 | 1 | _aGallego, Antonio | |
| 700 | 1 | _aRodriguez-Molina, Juan | |
| 700 | 1 | _aNavarro, Joaquin | |
| 700 | 1 | _aFernandez-Yañez, Juan | |
| 700 | 1 | _aPalomo, Jesus | |
| 700 | 1 | _aRodríguez-Hernández, Cesar | |
| 700 | 1 | _aRuiz, Manuel | |
| 700 | 1 | _aAlonso, Roberto | |
| 700 | 1 | _aFernandez-Cruz, Eduardo | |
| 700 | 1 | _aCarbone, Javier | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 9 _gno. 6 _gp. 649-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2008.09.013 _zAvailable from publisher's website |
| 999 |
_c18403398 _d18403398 |
||